ND CAPITAL
Edit

ND CAPITAL

https://nd.capital
Last activity: 08.05.2025
Active
Invests in categories: PlatformHealthTechHumanDrugBioTechTechnologyMedtechEngineeringToolsProduction
Portfolio
20
Persons
3
Mentions
15
Employees: 1-10

Portfolio 20

DateNameWebsiteTotal RaisedLocation
08.05.2022Nutcracker...nutcrackerx.com$227MUnited Sta...
04.01.2022Vandriavandria.com$51.3M-
05.05.2021Cytoki Pha...cytokipharma.com$45MDenmark, G...
-Ionpathionpath.com$18MUnited Sta...
-SQZ Biotec...sqzbiotech.com$164MUnited Sta...
-Amphivenaamphivena.com$62M-
-Orca Bioorcabio.com$300MUnited Sta...
-Visby Medi...visbymedical.com$235MUnited Sta...
-Serotinyserotiny.bio--
-Selecta Bi...selectabio.com$152.6MUnited Sta...
Show more

Persons 3

DateFirst NameLast NameTitleLinkedInLocation
-EricMoessingerPartner-
-AlisonPalmerVice Presi...-
-GabrielaEccoPrincipal-

Mentions in press and media 15

DateTitleDescription
08.05.2025HAYA Therapeutics: Pioneering the Future of RNA-Guided TherapiesIn the world of biotechnology, innovation is the lifeblood. HAYA Therapeutics has just secured a hefty $65 million in Series A funding, a financial boost that could change the landscape of chronic and age-related disease treatment. This fun...
08.05.2025HAYA Therapeutics banks $65 million Series A funding HAYA Therapeutics is a biotechnology company pioneering precision RNA-guided regulatory genome targeting therapeutics that reprogram disease-driving cell states for rare, common, chronic and age-related diseases. The core of HAYA’s proprie...
14.12.2023Vandria Announces $20.6M (CHF18M) Series A Financing Led by ND Capital to Drive CNS Clinical Program and Mitochondrial Therapeutics Platform-
25.09.2023Notify Therapeutics secures €5M to develop novel hormone-free fertility treatment for womenRead this article in: Copenhagen-based Notify Therapeutics, a “first-in-class” female fertility treatment, announced that it has secured €5M in a fresh round of funding. Notify Therapeutics, an initiative stemming from Professor Karin Lykke...
21.09.2023CHF 45 million Investment takes H55 next levelH55 is at the forefront of revolutionizing the aviation industry with its cutting-edge electric propulsion technologies. The company's groundbreaking solutions are designed to enhance the sustainability, efficiency, and safety of the aerosp...
05.05.2021Cytoki Pharma cierra una ronda de €38M liderada por Lundbeckfonden Emerge junto con Ysios Capital, Seventure Partners y +ND Capital05/05/2021 Nota de prensa YSIOS CAPITAL INVIERTE EN CYTOKI PHARMA. − La compañía biotecnológica Cytoki Pharma (Copenhague, Dinamarca) desarrolla nuevas proteínas basadas en interleuquina 22 (IL-22) para el tratamiento de lesiones epiteli...
05.05.2021Cytoki Pharma secures $45M Series A round lead by Lundbeckfonden Emerge together with Ysios, Seventure Partners and +ND Capital05/05/2021 Press release CYTOKI PHARMA RAISES $45 MILLION SERIES A FINANCING. Proceeds to support the development of its lead program (lipidated IL-22) through clinical proof of concept in Inflammatory Bowel Disease and explore expansion...
17.12.2020Energy storage investments 2020: VC and equity firms put more than $500 million in these 25 battery startupsWith U.S. energy storage growing a lot this year, and poised to accelerate next, conditions are fertile for VC investors to look for startup innovation.Source: Wood Mackenzie Here’s a long and incomplete list of where venture firms are putt...
04.12.2020Electric aircraft start-up H55 secures a CHF20 million investmentSilicon Valley-based firms, +ND Capital and Tippet Venture Partners led H55’s latest investment round. The funds will allow the company to expand its operations and engineering team to achieve the design and production certification from th...
04.12.2020Electric aircraft start-up H55 secures a CHF20 million investment
Show more

Reviews 0

Sign up to leave a review

Sign up Log In